No photo of Jama M Darling
Contact Expert

View Scopus Profile

Jama M Darling

    • 1167 Citations
    • 14 h-Index
    1991 …2020
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

    • 9 Similar Profiles
    Hepatitis C Medicine & Life Sciences
    Hepacivirus Medicine & Life Sciences
    Ribavirin Medicine & Life Sciences
    Genotype Medicine & Life Sciences
    Pigmented Villonodular Synovitis Medicine & Life Sciences
    Antiviral Agents Medicine & Life Sciences
    Liver Diseases Medicine & Life Sciences
    Matrix Metalloproteinase 3 Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 2004 2020

    Hepatitis B Research Network

    Fried, M. W., Evon, D. M., Darling, J. M. & McGivern, D.

    NIH National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDKD)

    9/30/08 → 5/31/20

    Project: Research project

    Hepatitis B
    Research
    Guidelines
    Therapeutics
    Chronic Hepatitis B

    AASLD NP/PA Hepatology Fellowship

    Darling, J. M.

    American Association for the Study of Liver Diseases (AASLD)

    7/1/13 → 6/30/14

    Project: Research project

    AI444-043-099 A Phase 3, Open Label Study of Safety and Efficacy with BMS-790052 plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)

    Darling, J. M.

    Industry Sponsor

    4/5/12 → 4/4/15

    Project: Research project

    WV21913 A Randomized, Open-label, Multicenter Study to Evaluate the Sustained Virologic Response of the HCV Protease Inhibitor Danoprevir Boosted with Low Dose Ritonavir (DNV/r) and Copegus, in Combination with the HCV Polymerase Inhibitor Prodrug RO5024048 and/or Pegasys in Chronic Hepatitis C Genotype 1 Patients Who Failed with a Previous Course of Peginterferon alfa plus Ribavirin Combination Therapy

    Darling, J. M.

    Industry Sponsor

    7/28/11 → 12/31/13

    Project: Research project

    P7977-0422 A Multi-center, Placebo-Controlled, Dose Ranging Study to Investig

    Darling, J. M.

    Industry Sponsor

    9/30/10 → 6/30/14

    Project: Research project

    Research Output 1991 2017

    • 1167 Citations
    • 14 h-Index
    • 18 Article
    • 3 Review article
    • 2 Editorial
    • 1 Chapter
    22 Citations

    Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: Results of the real-world, clinical practice HCV-TARGET study

    Welzel, T. M., Nelson, D. R., Morelli, G., Di Bisceglie, A., Reddy, R. K., Kuo, A., Lim, J. K., Darling, J., Pockros, P., Galati, J. S., Frazier, L. M., Alqahtani, S., Sulkowski, M. S., Vainorius, M., Akushevich, L., Fried, M. W. & Zeuzem, S., Oct 1 2017, In : Gut. 66, 10, p. 1844-1852 9 p.

    Research output: Contribution to journal › Article

    Ribavirin
    Genotype
    Safety
    Infection
    Fibrosis

    High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity

    Johansson, S., Talloen, W., Tuefferd, M., Darling, J., Fanning, G., Fried, M. W. & Aerssens, J., Mar 1 2016, In : Liver International. 36, 3, p. 344-352 9 p.

    Research output: Contribution to journal › Article

    Ribavirin
    Hepacivirus
    Genotype
    Chemokines
    Dipeptidyl Peptidase 4
    29 Citations

    Characteristics of adults in the hepatitis b research network in North America reflect their country of origin and hepatitis B virus genotype

    for the Hepatitis B Research Network, Jan 1 2015, In : Clinical Gastroenterology and Hepatology. 13, 1, p. 183-192 10 p.

    Research output: Contribution to journal › Article

    North America
    Hepatitis B
    Hepatitis B virus
    Hepatitis
    Genotype
    162 Citations

    Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study

    Chalasani, N., Bonkovsky, H. L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K. R., Watkins, P. B., Navarro, V., Barnhart, H., Gu, J., Serrano, J., Ahmad, J., Bach, N., Bansal, M., Barnhart, H. X., Beavers, K., Calvo, F. O., Chang, C., Conjeevaram, H. & 56 othersConner, G., Darling, J. M., De Boer, Y., Dieterich, D., Dipaola, F., Durazo, F. A., Everhart, J. E., Fontana, R. J., Ghabril, M. S., Goldstein, D., Gopalreddy, V., Grewal, P., Hayashi, P. H., Hoofnagle, J., Kaplowitz, N., Liangpunsakul, S., Lichtman, S. N., Liu, L., Navarro, V. J., Odin, J., Rossi, S., Russo, M., Schiano, T., Sherker, A. H., Vuppalanchi, R., Zacks, S. L., Balasco, A., Chesney, K., Corne, A., Cummings, S., Groseclose, G., Hammett, A., Hooker, J., Kesar, V., Mao, S., Marks, K., McFadden, R., Melgoza, Y., Mikhail, S., Milstein, S., Morlan, W., Peacock, V., Rosado, N., Russell, T., Vega, M., Verma, M., Walker, P., Yalamanchili, R., McClanahan-Crowder, M., Galan, K., Chau, T., Ragavan, K., Rostami, H., Puglisi-Scharenbroich, C., Torrance, R. J. & Van Raaphorst, R., Jun 1 2015, In : Gastroenterology. 148, 7, p. 1340-1352.e7

    Research output: Contribution to journal › Article

    Chemical and Drug Induced Liver Injury
    Prospective Studies
    Nitrofurantoin
    Liver Diseases
    Azithromycin
    2 Citations

    Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients

    Johansson, S., Talloen, W., Tuefferd, M., Darling, J. M., Scholliers, A., Fanning, G., Fried, M. W. & Aerssens, J., Nov 1 2015, In : Alimentary Pharmacology and Therapeutics. 42, 9, p. 1111-1121 11 p.

    Research output: Contribution to journal › Article

    Platelet Count
    Oncogenes
    Hepacivirus
    Fibrosis
    Ribavirin